From Casetext: Smarter Legal Research

U.S. v. Magana

United States Court of Appeals, Ninth Circuit
Jan 13, 2003
60 F. App'x 3 (9th Cir. 2003)

Opinion


60 Fed.Appx. 3 (9th Cir. 2003) UNITED STATES of America, Plaintiff-Appellee, v. Jose Gonzalez MAGANA, Defendant-Appellant. United States of America, Plaintiff-Appellee, v. Alfonso Perez Alcantar, Defendant-Appellant. Nos. 98-10487, 99-10165. D.C. No. CR-97-05167-MDC. United States Court of Appeals, Ninth Circuit. January 13, 2003

Submitted July 6, 2000

Vacated and Remanded Jan. 8, 2001.

Resubmitted Jan. 7, 2002.

The panel unanimously finds this case suitable for decision without oral argument. See Fed. R.App. P. 34(a)(2).

NOT FOR PUBLICATION. (See Federal Rule of Appellate Procedure Rule 36-3)

Defendants were convicted for conspiracy to manufacture, distribute, and possess methamphetamine with intent to distribute, as well as other drug charges, following entry of guilty plea by one defendant and jury trial of other defendant, by the United States District Court for the Eastern District of California, M.D. Crocker, J. Defendants appealed. Following remand, 531 U.S. 1063, 121 S.Ct. 751, 148 L.Ed.2d 655, the Court of Appeals held that due process violation of sentencing defendants under federal drug statute setting forth prohibited acts, based upon determination by judge that quantity of drugs as proven at trial was sufficient to account for level that presentence report gave defendant, was harmless error.

Affirmed.

Before NOONAN, THOMAS and BERZON, Circuit Judges.

MEMORANDUM

This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as may be provided by Ninth Circuit Rule 36-3.

On Remand from the United States Supreme Court

Defendants Magana and Alcantar were indicted for conspiracy to manufacture, distribute, and possess methamphetamine with intent to distribute; they were also indicted for aiding and abetting the manufacture of methamphetamine and the possession of methamphetamine with the intent to distribute. Both Magana and Alcantar were convicted, Alcantar pursuant to a guilty plea. Magana appealed his conviction, and Alcantar appealed the judgment entered pursuant to his guilty plea.

On July 12, 2000, this Court filed a memorandum disposition affirming the district court's decisions with respect to both Magana and Alcantar. About five months later, on January 8, 2001, the Supreme Court vacated our decision and remanded for reconsideration in light of Apprendi v. New Jersey, 530 U.S. 466, 120 S.Ct. 2348, 147 L.Ed.2d 435 (2000). Magana v. United States, 531 U.S. 1063, 121 S.Ct. 751, 148 L.Ed.2d 655 (2001). The parties filed briefs with this Court accordingly.

The Apprendi issue raised in this case is whether the penalty provision of the federal drug statute under which the defendants were sentenced--namely, 21 U.S.C. § 841--violates, under Apprendi, the due process clause of the United States Constitution because it permitted the imposition of a particular sentence based on certain factors--such as the quantity of drugs at issue--that were not found beyond reasonable doubt by the jury.

In United States v. Buckland, 289 F.3d 558 (9th Cir.2002) (en banc), we were confronted with, and we answered, almost precisely this question. See United States v. Hernandez, 2002 WL 31887902, *5 (9th Cir.2002) (rejecting the argument that the Supreme Court's opinion in Harris v. United States, 536 U.S. 545, 122 S.Ct. 2406, 153 L.Ed.2d 524 (2002), overrules, undermines, or disputes Buckland' s "continuing validity"). As a threshold matter, we found in Buckland that the relevant statutory provisions were not facially unconstitutional. Buckland, 289 F.3d at 564-66. Holding that due process requires drug quantity and type to be treated as would any other material fact in a criminal prosecution, though, we also found in Buckland that these facts must be "charged in the indictment, submitted to the jury, subject to the rules of evidence, and proved beyond a reasonable doubt." Id. at 568.

In Buckland, as here, these procedural requirements were not met: in this case, a jury did not find beyond a reasonable doubt that the quantity of drugs in question sufficed for conviction under the particular provisions of § 841; instead, the sentencing court--and not the jury--declared that "... the quantity of drugs ... [as] proven at trial should be sufficient to account for the level 38 that the presentence report gives the defendant." In this sense, as in Buckland, we are confronted here with an Apprendi error.

But this conclusion alone does not end our analysis. Because we determined in Buckland that it was beyond all doubt that the Apprendi error did not affect the outcome of the proceedings, we affirmed the defendant's conviction nevertheless. Buckland, 289 F.3d at 569-70. We find that the same analysis and conclusion obtain here: in this case, as in Buckland, there was an Apprendi error, but, as in Buckland, this Apprendi error was harmless with regard to the defendants' convictions and sentences. Our careful review of the evidence confirms that, as in Buckland, a rational jury would have found the requisite quantity of drugs to have existed beyond a reasonable doubt; that is, "the Apprendi error in this case did not affect the outcome of the proceedings." Buckland, 289 F.3d at 568. As a result, this case mirrors Buckland and we conclude accordingly that the Apprendi error was

Page 5.

harmless. Thus, we affirm the district court's decision in all parts.

AFFIRMED.


Summaries of

U.S. v. Magana

United States Court of Appeals, Ninth Circuit
Jan 13, 2003
60 F. App'x 3 (9th Cir. 2003)
Case details for

U.S. v. Magana

Case Details

Full title:UNITED STATES of America, Plaintiff-Appellee, v. Jose Gonzalez MAGANA…

Court:United States Court of Appeals, Ninth Circuit

Date published: Jan 13, 2003

Citations

60 F. App'x 3 (9th Cir. 2003)

Citing Cases

Tekoh v. Cnty. of Los. Angeles.

60 (9th Cir. July 19, 2011); United States v. Quinones, 135 F. App'x 64, 65-66 (9th Cir. June 14, 2005);…